Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Blood Pressure and Lipids Reduction in High Risk Elderly Patients With Isolated Systolic Hypertension
NCT05165251Phase 4Unknown
- Sponsor
- Shanghai Jiao Tong University School of Medicine
- Start
- Jan 2022
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of amlodipine + atorvastatin in isolated systolic hypertension (ISH) (3 arms), sponsored by Shanghai Jiao Tong University School of Medicine. Primary endpoint: Change in mean office systolic blood pressure at 12 months. Status: unknown.
02
Drugs
amlodipine + atorvastatin
03
Conditions
isolated systolic hypertension (ISH)
Beyond the preview
Go deeper on NCT05165251.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05165251.